| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/18/2003 | WO2003104809A1 Solid phase substrate for immobilizing biomolecules |
| 12/18/2003 | WO2003104808A1 New probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003104806A1 Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same |
| 12/18/2003 | WO2003104805A1 Bioassay unit and substrate for bioassay |
| 12/18/2003 | WO2003104804A1 Methods of searching for substance having antidiabetic effect |
| 12/18/2003 | WO2003104803A2 Method for mapping and eliminating t-cell epitopes |
| 12/18/2003 | WO2003104802A1 Electrospray tandem mass spectrometry for newborn screening |
| 12/18/2003 | WO2003104800A1 Identification of proteins present in complex mixtures |
| 12/18/2003 | WO2003104798A1 Method for analysing a working fluid using impedance spectroscopy |
| 12/18/2003 | WO2003104797A1 Methods and apparatus for harvesting vaccine from eggs |
| 12/18/2003 | WO2003104796A1 Portable vehicle exhaust analyzer module |
| 12/18/2003 | WO2003104795A1 Analysis of mercury containing samples |
| 12/18/2003 | WO2003104794A1 A method for analyzing the spatial distribution of a chemical substance retained by a biological matter |
| 12/18/2003 | WO2003104789A1 MULTIFUNCTIONAL BIOSENSOR BASED ON ZnO NANOSTRUCTURES |
| 12/18/2003 | WO2003104788A1 Extracellular potential measuring device and method for fabricating the same |
| 12/18/2003 | WO2003104787A1 Sensor and sensing method for detection and process control |
| 12/18/2003 | WO2003104785A1 Measurement and monitoring system of dairy stock and plant |
| 12/18/2003 | WO2003104782A1 Directional coupler sensor for measuring moisture of hair |
| 12/18/2003 | WO2003104778A1 Methods for identifying ligands using competitive binding <1>h nmr experiments |
| 12/18/2003 | WO2003104777A1 Method and apparatus for determining wood parameters, including grain angle |
| 12/18/2003 | WO2003104776A1 Method and apparatus for determining wood parameters, including grain length |
| 12/18/2003 | WO2003104773A1 Apparatus for measuring green-speed |
| 12/18/2003 | WO2003104772A1 A disposable cartridge for characterizing particles suspended in a liquid |
| 12/18/2003 | WO2003104771A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells |
| 12/18/2003 | WO2003104770A2 A disposable cartridge for characterizing particles suspended in a liquid |
| 12/18/2003 | WO2003104765A2 Total organic carbon (toc) analyzer |
| 12/18/2003 | WO2003104764A2 Automated immunoassay cassette, apparatus and mehtod |
| 12/18/2003 | WO2003104762A2 Protein micro-arrays and multi-layered affinity interaction detection |
| 12/18/2003 | WO2003104761A2 Measurement of melanocortin peptides and uses thereof |
| 12/18/2003 | WO2003104752A2 Water cut rate of change analytic method |
| 12/18/2003 | WO2003104685A2 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof |
| 12/18/2003 | WO2003104572A1 Water supply monitoring for contaminant detection |
| 12/18/2003 | WO2003104496A1 Type i interferon-inducible proteins to detect viral infection |
| 12/18/2003 | WO2003104490A2 Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof |
| 12/18/2003 | WO2003104488A1 Eef1a2 for use in the prognosis, diagnosis and treatment of cancer |
| 12/18/2003 | WO2003104486A1 Method of selectively measuring triglycerides |
| 12/18/2003 | WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/18/2003 | WO2003104484A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators |
| 12/18/2003 | WO2003104482A1 Signals and molecular species involved in senescence |
| 12/18/2003 | WO2003104480A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 12/18/2003 | WO2003104479A2 Identification of inhibitors of mitosis |
| 12/18/2003 | WO2003104478A2 Detection of rna structural elements |
| 12/18/2003 | WO2003104466A1 Treatment of vascular dysfunction and alzheimer's disease |
| 12/18/2003 | WO2003104460A1 Pigment protein |
| 12/18/2003 | WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease |
| 12/18/2003 | WO2003104454A1 Novel oxidase |
| 12/18/2003 | WO2003104447A1 Fluorescent detection of peroxidase enzymes |
| 12/18/2003 | WO2003104442A1 Methods of regulating differentiation in stem cells |
| 12/18/2003 | WO2003104434A2 A method to amplify variable sequences without imposing primer sequences |
| 12/18/2003 | WO2003104431A2 Transgenic mammals expressing polyglutamine |
| 12/18/2003 | WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 12/18/2003 | WO2003104424A2 Novel molecular conjugates for signal amplification |
| 12/18/2003 | WO2003104421A2 Immunocapture and functional assay for mitochondrial f1/f0 atpase |
| 12/18/2003 | WO2003104415A2 Method to screen ligands using eukaryotic cell display |
| 12/18/2003 | WO2003104384A1 Reactor systems having a light-interacting component |
| 12/18/2003 | WO2003104363A2 Determining fluid composition from fluid properties |
| 12/18/2003 | WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain |
| 12/18/2003 | WO2003104263A2 Cytokines and cytokine receptors with reduced immunogenicity |
| 12/18/2003 | WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
| 12/18/2003 | WO2003104252A1 Biodetection method |
| 12/18/2003 | WO2003104236A1 Calcitonin gene related peptide receptor antagonists |
| 12/18/2003 | WO2003104181A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 12/18/2003 | WO2003103864A1 Method and system for reducing landfill methane emissions |
| 12/18/2003 | WO2003103771A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 12/18/2003 | WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/18/2003 | WO2003103709A2 Modulation of bone development |
| 12/18/2003 | WO2003103676A2 Method of treating cancer using kinase inhibitors |
| 12/18/2003 | WO2003103662A2 Inhibitors of glycoprotein vi |
| 12/18/2003 | WO2003103613A2 Induction of insulin expression |
| 12/18/2003 | WO2003103607A2 Viral envelope mediated fusion assay |
| 12/18/2003 | WO2003103606A2 Methods and compositions for treating and diagnosing diabetes |
| 12/18/2003 | WO2003103601A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/18/2003 | WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/18/2003 | WO2003103593A2 Secretases related to alzheimer's dementia |
| 12/18/2003 | WO2003103579A2 High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders |
| 12/18/2003 | WO2003103481A2 Methods for detecting b. anthracis infection |
| 12/18/2003 | WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 12/18/2003 | WO2003103399A1 Method and arrangement related to a dough forming |
| 12/18/2003 | WO2003087835A8 Haptoglobin fragments diagnostic of alzheimers disease |
| 12/18/2003 | WO2003085752A3 Molehole embedded 3-d crossbar architecture used in electrochemical molecular memory device |
| 12/18/2003 | WO2003083463A3 Apparatus and method for electrochemical detection and control of inorganic scale |
| 12/18/2003 | WO2003078050A3 A building block forming a c-c bond upon reaction |
| 12/18/2003 | WO2003076937A3 Apparatus and methods for analyte measurement and immunoassay |
| 12/18/2003 | WO2003074549A3 Assay for anti-ingap antibodies |
| 12/18/2003 | WO2003067904A3 High-throughput cell identification and isolation method and apparatus |
| 12/18/2003 | WO2003067263A3 Assay |
| 12/18/2003 | WO2003067210A3 Methods and compositions for detecting the activation state of the multiple proteins in single cells |
| 12/18/2003 | WO2003064994A3 Methods of collecting and analyzing human breath |
| 12/18/2003 | WO2003060653A3 Method and/or system for analyzing biological samples using a computer system |
| 12/18/2003 | WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 12/18/2003 | WO2003058205A3 Methods of identifying putative effector proteins |
| 12/18/2003 | WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 12/18/2003 | WO2003057159A3 Psoriasin expression by breast epithelial cells |
| 12/18/2003 | WO2003056031A3 Method and kit for detecting alkaline sphingomyelinase |
| 12/18/2003 | WO2003052382A3 Integrated protein affinity capture centrifugation device |
| 12/18/2003 | WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/18/2003 | WO2003050535A3 Method for determining the influence of non-physiological compounds the derivatives and decomposition products thereof on organisms organs and cells |
| 12/18/2003 | WO2003049599A3 Methods and compositions for the diagnosis of asthma |
| 12/18/2003 | WO2003048784A3 Internal standards for sphingolipids for use in mass spectrometry |